US Patent 8728170 Bioerodible nano-fibrous and nano-porous conductive composites
Patent 8728170 was granted and assigned to Boston Scientific on May, 2014 by the United States Patent and Trademark Office.
All edits
Edits on 16 Oct, 2024
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 2 Dec, 2023
Golden AI
Edits made to:
Article (+103 characters)
Article
Patent abstract
A bioerodible conductive tissue scaffold that can provide, e.g., improved tissue growth.
Edits on 22 Jul, 2023
Golden AI
Edits made to:
Infobox (-1 properties)
Infobox
Official Website
Edits on 24 May, 2023
Golden AI
Edits made to:
Infobox (+1/-1 properties)
US Patent 08728170 Bioerodible nano-fibrous and nano-porous conductive composites US Patent 8728170 Bioerodible nano-fibrous and nano-porous conductive composites
Infobox
Patent Number
0872817000
Patent Number
872817000
Edits on 26 Apr, 2023
Golden AI
Infobox
Is a
Current Assignee
Patent Jurisdiction
Patent Number
087281700
Date of Patent
May 20, 2014
0Patent Application Number
116944360
Date Filed
March 30, 2007
0Official Website
Patent Primary Examiner
Edits on 28 Sep, 2022
Golden AI
Infobox
Is a
Current Assignee
Patent Jurisdiction
Patent Number
087281700
Date of Patent
May 20, 2014
0Patent Application Number
116944360
Date Filed
March 30, 2007
0Official Website
Patent Primary Examiner
Edits on 19 Jun, 2022
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Website URL
Edits on 23 Dec, 2021
Golden AI
Edits made to:
Infobox (+8 properties)
US Patent 08728170 Bioerodible nano-fibrous and nano-porous conductive composites
Infobox
Is a
Current assignee
Patent jurisdiction
Patent number
08728170
Date of patent
May 20, 2014
Patent application number
11694436
Date Filed
March 30, 2007
Patent primary examiner
Find more entities like US Patent 8728170 Bioerodible nano-fibrous and nano-porous conductive composites
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.